Fig. 3From: Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trialSubgroup analyses for the primary outcome (Short Physical Performance Battery). Values are mean and 95% CIBack to article page